TACN - ETF AI Analysis
Top Page
T. Rowe Price Active Core International Equity ETF (TACN)
Rating:66Neutral
Price Target:―
Positive Factors
Leading Global Companies in Top Holdings
The fund’s largest positions include several well-known international leaders that have shown strong or steady performance, which can help support overall returns.
Broad International Diversification
Holdings spread across many countries such as Japan, the UK, France, Germany, and others help reduce the impact of problems in any single market.
Balanced Sector Mix
Exposure across financials, industrials, health care, consumer sectors, and technology provides a mix of growth and stability rather than relying on just one industry.
Negative Factors
Recent Weak Performance
The ETF has shown weak returns over the past month and year-to-date, which may concern investors looking for near-term strength.
Underperforming Key Holdings
Some notable positions, including a major electronics company and certain health care and financial names, have lagged recently and may be dragging on the fund’s results.
Concentration in Financials and Japan
A relatively large weight in financial stocks and significant exposure to Japan means the fund could be more sensitive to downturns in that sector or country.
TACN vs. SPDR S&P 500 ETF (SPY)
AUM18.45M
RegionDeveloped Markets
Expense Ratio0.00%
Beta1.11
IssuerT. Rowe Price
Inception DateN/A
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,385
30 Day Avg. Volume4,088
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
43.76Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering485
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TACN Summary
The T. Rowe Price Active Core International Equity ETF (TACN) is an actively managed fund that invests in a wide range of companies outside the U.S., mainly in countries like Japan, the UK, and France. It doesn’t track a fixed index, but instead relies on T. Rowe Price managers to pick stocks across many sectors, including financials, industrials, and health care. Well-known holdings include ASML, Nestlé, Sony, and AstraZeneca. Investors might consider TACN for international diversification and long-term growth potential. A key risk is that foreign stock prices can go up and down with global markets and currency swings.
How much will it cost me?The T. Rowe Price Active Core International Equity ETF (TACN) has an expense ratio of 0.0%, meaning you won’t pay any annual fees for every $1,000 invested. This is significantly lower than average, as most ETFs, especially actively managed ones like TACN, typically charge fees to cover management costs. This makes it an exceptionally cost-effective option for investors.
What would affect this ETF?The T. Rowe Price Active Core International Equity ETF (TACN) could benefit from economic growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of its portfolio. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or currency fluctuations that could impact international investments. Additionally, sector-specific risks, such as volatility in energy or technology, could influence the ETF's performance.
TACN Top 10 Holdings
TACN leans heavily into developed markets outside North America, with Europe doing much of the heavy lifting. ASML has been a key engine for the fund this year, though its recent wobble shows that semiconductor strength can still be bumpy. Shell has been a bright spot, giving the portfolio an energy tailwind, while AstraZeneca and Novartis provide steady health care ballast. On the flip side, Roche and Sony have been losing steam, acting as mild brakes on performance. Financials like HSBC add to the fund’s international banking tilt without dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.13% | $558.32K | €443.48B | 103.63% | 76 Outperform | |
| AstraZeneca | 1.80% | $322.02K | $314.02B | 41.71% | 80 Outperform | |
| Shell (UK) | 1.51% | $270.12K | £198.91B | 42.80% | 73 Outperform | |
| Novartis AG | 1.41% | $251.20K | CHF224.91B | 33.87% | 80 Outperform | |
| Roche Holding AG | 1.38% | $245.70K | $318.62B | 33.77% | 73 Outperform | |
| HSBC Holdings | 1.19% | $211.90K | £218.71B | 67.47% | 80 Outperform | |
| Nestlé SA | 1.05% | $186.64K | CHF198.22B | -2.56% | 71 Outperform | |
| Sony | 0.97% | $173.29K | ¥20.31T | -9.85% | 73 Outperform | |
| Iberdrola | 0.93% | $166.61K | €135.99B | 33.27% | 67 Neutral | |
| Banco Bilbao Vizcaya Argentaria | 0.93% | $166.53K | €106.89B | 69.16% | 76 Outperform |
TACN Technical Analysis
Positive
―
Price Trends
26.89
Negative
Market Momentum
-0.29
Negative
50.17
Neutral
96.20
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TACN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 25.96, equal to the 50-day MA of 26.89, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.29 indicates Negative momentum. The RSI at 50.17 is Neutral, neither overbought nor oversold. The STOCH value of 96.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TACN.
TACN Peer Comparison
Comparison Results
Performance Comparison
TACN
T. Rowe Price Active Core International Equity ETF
26.25
0.95
3.75%
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
QUIZ
Zacks Quality International ETF
―
―
―
AIVI
WisdomTree International AI Enhanced Value Fund
―
―
―
IVSI
Applied Finance IVS International Large ETF
―
―
―
PQNT
Pictet AI Enhanced International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents